• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Asia Pacific Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 (Japan, South Korea, Australia) (Executive Summary)

  • ID: 1878318
  • September 2011
  • Region: Asia, Asia Pacific, Australia, Japan, South Korea
  • 7 Pages
  • iData Research

The total Asia-Pacific market for cosmetic surgery, facial aesthetics and medical laser devices was valued at over $715 million in 2010. The segments covered in this report include:

- Botulinum Toxin A
-- Cosmetic Uses
-- Non-cosmetic Uses

- Dermal Fillers
-- Hyaluronic Acid
-- Polymer and Particle Based Fillers
-- Fat Injection
-- Cellular Treatment / Stem Cells

- Augmentation Implants
-- Saline Implants
-- Silicone Implants

- Laser/Light/Radiofrequency
-- Intense Pulsed Light
-- Laser Hair Removal
-- Skin Treatments

Within the Asia Pacific Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 (made up of South Korea, Japan and Australia), Allergan, Mentor, Q-Med and Cutera lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

This is an executive summary only, the full-report is also available for purchase.

Note: Product cover images may vary from those shown

Executive Summary

1.1 Asia-Pacific Markets For Cosmetic Surgery, Facial Aesthetics And Medical Laser Devices

1.2 Growth Trends

1.3 Procedure Numbers

1.4 Japan

1.5 South Korea

1.6 Australia

1.7 Competitive Analysis

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

ALSO AVAILABLE

RELATED PRODUCTS

Our Clients

STILLE Surgical Instruments Alcon Incorporated Hoya Surgical Optics, Inc. Hollister Inc. PerkinElmer, Inc. Cyberonics, Inc.